The stock price of Intellia Therapeutics Inc (NASDAQ: NTLA) has surged by 0.55 when compared to previous closing price of 7.25, but the company has
The stock of Intellia Therapeutics Inc (NTLA) has gone down by -0.47% for the week, with a 22.50% rise in the past month and a
Intellia Therapeutics Inc (NASDAQ: NTLA)’s stock price has soared by 2.05 in relation to previous closing price of 8.31. Nevertheless, the company has seen a
NTLA has 36-month beta value of 2.28. Analysts have mixed views on the stock, with 17 analysts rating it as a “buy,” 4 as “overweight,”
Company’s 36-month beta value is 2.31.Analysts have differing opinions on the stock, with 17 analysts rating it as a “buy,” 4 as “overweight,” 7 as
Intellia Therapeutics Inc (NASDAQ: NTLA)’s stock price has decreased by -1.36 compared to its previous closing price of 6.63. However, the company has seen a
Intellia Therapeutics Inc (NASDAQ: NTLA)’s stock price has gone decline by -11.13 in comparison to its previous close of 8.07, however, the company has experienced
Moreover, the 36-month beta value for NTLA is 2.14. Analysts have varying opinions on the stock, with 17 analysts rating it as a “buy,” 4
© 2024, Powered by Smart TechOne
